+Advanced Search
Home > Archive>Volume 26, Issue 6, 2016 >88-93. DOI:10.3969.j.issn.1671.7856.2016.006.016
PDF HTML XML Export Cite reminder
Introduction and research progress of animal models of pulmonary fibrosis
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [37]
    • | | | |
  • Comments
    Abstract:

    Pulmonary fibrosis can severely disrupt lung functions, but its etiology and pathogenesis remain unclear. Animal models of lung fibrosis play an important role in investigation of the mechanism by which pulmonary fibrosis develops. This review summarizes the characteristics, advantages, and disadvantages of widely used and newly established animal models of lung fibrosis.

    Reference
    [1] Molina-Molina M, Pereda J, Xaubet A.
    [Experimental models for the study of pulmonary fibrosis: current usefulness and future promise] [J]. Arch Bronconeumol, 2007, 43(9): 501-507.
    [2] Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias [J]. Eur Resp J, 2002, 19(5): 794-796.
    [3] Travis W D, Costabel U, Hansell D M, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias [J]. Am J Resp Crit Care Med, 2013, 188(6): 733-748.
    [4] Morgan G W, Breit S N. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury [J]. Int J of radiation Oncol, Biol, phys, 1995, 31(2): 361-369.
    [5] Adamson IY. Pulmonary toxicity of bleomycin [J]. Environ health persp, 1976, 16:119-126.
    [6] Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? [M]. Int J Biochem cell biol. 2008: 362-382.
    [7] Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis [J]. Am J physiol Lung Cell Mol Physio, 2008, 294(2): L152-160.
    [8] Aoshiba K, Tsuji T, Nagai A. Bleomycin induces cellular senescence in alveolar epithelial cells [J]. Eur Resp J, 2003, 22(3): 436-443.
    [9] Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers [J]. Am J Respir Cell Mol Biol, 2005, 33(1): 9-13.
    [10] B. Moore B, Lawson WE, Oury TD, et al. Animal models of fibrotic lung disease [J]. Am J Resp Cell Mol, 2013, 49(2): 167-179.
    [11] Sanchez VC, Pietruska JR, Miselis NR, et al. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? [J]. Wiley Interdiscipl Rev Nanomed Nanobiotechnol, 2009, 1(5): 511-529.
    [12] Oberdorster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles [J]. Inhalation Toxicology, 1996, 8 Suppl:73-89.
    [13] Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time, and genetic strain [J]. J Environ Pathol, Toxicol Oncol, 1998, 17(2): 81-97.
    [14] Barbarin V, Nihoul A, Misson P, et al. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis [J]. Resp Res, 2005, 6:112.
    [15] Lakatos HF, Burgess HA, Thatcher TH, et al. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation [J]. Exp Lung Res, 2006, 32(5): 181-199.
    [16] Cassel SL, Eisenbarth SC, Iyer SS, et al. The Nalp3 inflammasome is essential for the development of silicosis [J]. Proc Natl Acad Sci U S A, 2008, 105(26): 9035-9040.
    [17] Moore BB, Murray L, Das A, et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis [J]. Am J Respir Cell Mol Biol, 2006, 35(2): 175-181.
    [18] Moore BB, Paine R, 3rd, Christensen PJ, et al. Protection from pulmonary fibrosis in the absence of CCR2 signaling [J]. J Immunol, 2001, 167(8): 4368-4377.
    [19] Christensen PJ, Goodman RE, Pastoriza L, et al. Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent [J]. Am J Pathol, 1999, 155(5): 1773-1779.
    [20] McDonald S, Rubin P, Chang AY, et al. Pulmonary changes induced by combined mouse beta-interferon (rMuIFN-beta) and irradiation in normal mice--toxic versus protective effects [J]. Radiother Oncol, 1993, 26(3): 212-218.
    [21] Epperly MW, Guo H, Gretton JE, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis [J]. Am J Respir Cell Mol Biol, 2003, 29(2): 213-224.
    [22] Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosis--familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis [J]. Am J Med Sci, 2011, 341(6): 439-443.
    [23] Lawson WE, Cheng DS, Degryse AL, et al. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs [J]. Proc Natl Acad Sci U S A, 2011, 108(26): 10562-10567.
    [24] Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer [J]. Am J human Genet, 2009, 84(1): 52-59.
    [25] Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis [J]. New Engl J of Med, 2007, 356(13): 1317-1326.
    [26] Fernandez IE, Eickelberg O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers [J]. Proc Am Thorac Soc, 2012, 9(3): 111-116.
    [27] Morimoto Y, Kim H, Oyabu T, et al. Effect of long-term inhalation of toner on extracellular matrix in the lungs of rats in vivo [J]. Inhalation Toxicol, 2005, 17(3): 153-159.
    [28] Sullivan DE, Ferris M, Pociask D, et al. Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway [J]. Am J Respir Cell Mol Biol, 2005, 32(4): 342-349.
    [29] Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis [J]. J Exp Med, 2004, 200(3): 377-389.
    [30] Chung MP, Monick MM, Hamzeh NY, et al. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis [J]. Am J Respir Cell Mol Biol, 2003, 29(3 Pt 1): 375-380.
    [31] Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases [J]. Human pathol, 2008, 39(9): 1275-1294.
    [32] Degryse AL, Tanjore H, Xu XC, et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis [J]. Am J Physiol Lung Cell Mol physiol, 2010, 299(4): L442-452.
    [33] Sueblinvong V, Neveu WA, Neujahr DC, et al. Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury [J]. Adv Biosci Biotechnol, 2014, 5(1): 19-30.
    [34] Redente EF, Jacobsen KM, Solomon JJ, et al. Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis [J]. Am J physiol Lung Cell Mol Physio, 2011, 301(4): L510-518.
    [35] Sueblinvong V, Neujahr DC, Mills ST, et al. Predisposition for disrepair in the aged lung [J]. Am J Med Sci, 2012, 344(1): 41-51.
    [36] Pierce EM, Carpenter K, Jakubzick C, et al. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice [J]. Am J pathol, 2007, 170(4): 1152-1164.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Copy
Share
Article Metrics
  • Abstract:2280
  • PDF: 6155
  • HTML: 0
  • Cited by: 0
History
  • Revised:December 10,2015
  • Online: June 30,2016
Article QR Code
You are the first3046897 Visitors
® 2025 All Rights Reserved
Address：5 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China Postcode： Phone：86-10-67779337 E-mail:bjb@cnilas.org
Supported by:Beijing E-Tiller Technology Development Co., Ltd.